moxifloxacin has been researched along with Eperythrozoonosis in 44 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (9.09) | 29.6817 |
2010's | 25 (56.82) | 24.3611 |
2020's | 15 (34.09) | 2.80 |
Authors | Studies |
---|---|
Crabb, DM; Duffy, LB; Waites, KB | 1 |
Bodiyabadu, K; Bradshaw, CS; Chow, EPF; Doyle, M; Fairley, CK; Jensen, JS; Murray, GL; Plummer, EL; Sweeney, E; Vodstrcil, LA; Whiley, D; Williamson, DA | 1 |
Cusini, M; Gomberg, M; Jensen, JS; Moi, H; Unemo, M; Wilson, J | 1 |
Bodiyabadu, K; Bradshaw, CS; Danielewski, J; Garland, SM; Machalek, DA; Murray, GL; Plummer, EL; Sweeney, EL; Vodstrcil, LA; Whiley, DM | 1 |
Bébéar, C; Gardette, M; Guiraud, J; Hénin, N; Le Roy, C; Pereyre, S; Touati, A | 1 |
Bodiyabadu, K; Bradshaw, CS; Chua, TP; Danielewski, JA; Doyle, M; Garland, S; Huaman, JL; Machalek, DA; Murray, GL; Plummer, EL; Sweeney, EL; Vodstrcil, LA; Whiley, DM | 1 |
Aguirre, I; Bradshaw, CS; Chen, MY; Chow, EPF; Doyle, M; Durukan, D; Fairley, CK; Mokany, E; Murray, G; Read, TRH; Tan, LY; Vodstrcil, LA | 1 |
Fernández, J; Vazquez, F | 1 |
Cross, ELA; Hassan-Ibrahim, MO; Ovens, KJ; Reynolds-Wright, JJ; Rickwood, L; Soni, S | 1 |
Bone, S; Conway, RJH; Cook, S; Hassan-Ibrahim, MO; Malone, C; Soni, S | 1 |
Braam, JF; Kusters, JG; van der Schalk, TE | 1 |
Bodiyabadu, K; Bradshaw, CS; Danielewski, J; Durukan, D; Fairley, CK; Garland, SM; Jensen, JS; Machalek, DA; Mokany, E; Murray, GL; Tan, LY; Williamson, DA | 1 |
Jensen, JS; Manhart, LE | 1 |
Berman, DM; Messina, A; Namtu, K; Nohren, J; Peloquin, C; Tuite, G | 1 |
Bradshaw, CS; Chow, EPF; Fairley, CK; Garland, SM; Hocking, JS; Jensen, JS; Low, N; Machalek, DA; Murray, G; Shilling, H; Tao, Y; Unemo, M; Vodstrcil, LA; Zhang, L | 1 |
Ke, W; Yang, L | 1 |
Bertholet, L; Blore, B; Brandley, J; Bull, A; Chernesky, M; Gratrix, J; Martin, I; Naidu, P; Parker, P; Plitt, S; Read, R; Scarrott, R; Shokoples, S; Singh, A; Smyczek, P; Turnbull, L | 1 |
Aung, E; Bradshaw, CS; Chen, MY; Chow, EPF; Fairley, CK; Garland, SM; Murray, G; Ong, JJ; Read, TRH | 1 |
Lu, B; Xiang, L | 1 |
Auguste, U; Labbé, AC; Singh, AE | 1 |
Macía, M; Navarro, D; Romay, AB; Trastoy, R; Treviño, M; Veiga, E | 1 |
Couldwell, DL; Gilbert, GL; Jeoffreys, NJ; Tagg, KA | 1 |
Fernandes, P; Jensen, JS; Unemo, M | 1 |
Taylor-Robinson, D | 1 |
Balkman, JD; Ball, PA; Bauer, DF; Lollis, SS; Whitson, WJ | 1 |
Abdo, H; Bissessor, M; Bradshaw, CS; Chen, MY; Fairley, CK; Garland, SM; Hocking, JS; Jensen, JS; Tabrizi, SN; Twin, J; Vodstrcil, LA | 1 |
Haugstvedt, A; Jensen, JS; Moi, H | 1 |
Blee, K; Evans, C; Horner, P; Muir, P; O'Mahony, C; Radcliffe, K | 1 |
Enger, M; Falk, L; Jensen, JS | 1 |
Bradshaw, C; Jensen, JS | 1 |
Maatouk, I | 1 |
Allen, V; Gesink, D; Greer, J; Jamieson, H; Jensen, JS; Juzkiw, J; Mitterni, L; Racey, CS; Seah, C; Singh, S; Zittermann, S | 1 |
Alcaraz, I; Bertolotti, A; Derancourt, C; Dupin, N; Janier, M; Milpied, B | 1 |
Cao, YP; Le, WJ; Li, S; Li, Y; Su, XH | 1 |
Bébéar, C; Bébéar, CM; Clerc, M; de Barbeyrac, B; Pereyre, S; Renaudin, H | 1 |
Jernberg, E; Moghaddam, A; Moi, H | 1 |
Benjamin, DK; Cohen-Wolkowiez, M; Laughon, MM; Massaro, MM; Smith, B; Watt, KM | 1 |
Izumi, K; Mikamo, H; Ohki, E; Terada, M; Yamagishi, Y | 1 |
Barker, EN; Chalker, VJ; Hamon, M; Jensen, J; Mitchell, J; Steer, JA; Stocki, T; Tasker, S | 1 |
Broad, JM; Golden, MR; Manhart, LE | 1 |
Stiles, BG; Weinstein, SA | 1 |
Deguchi, T; Hagiwara, N; Ito, S; Maeda, S; Yasuda, M | 1 |
Chia, JH; Huang, CT; Kuo, AJ; Leu, HS; Lu, SC; Wu, TS; Yu, KH | 1 |
Bradshaw, CS; Fairley, CK; Garland, SM; Hopkins, CA; Jensen, JS; Moss, LM; Read, TR; Tabrizi, SN | 1 |
8 review(s) available for moxifloxacin and Eperythrozoonosis
Article | Year |
---|---|
Molecular basis of antimicrobial resistance in Mycoplasma genitalium.
Topics: Anti-Bacterial Agents; Azithromycin; Doxycycline; Drug Resistance, Bacterial; Female; Female Urogenital Diseases; Humans; Male; Male Urogenital Diseases; Microbial Sensitivity Tests; Moxifloxacin; Mycoplasma genitalium; Mycoplasma Infections; Polymorphism, Single Nucleotide; Sexually Transmitted Diseases, Bacterial | 2020 |
Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Azithromycin; Carrier Proteins; Drug Resistance, Bacterial; Female; Humans; Male; Moxifloxacin; Mutation; Mycoplasma genitalium; Mycoplasma Infections; Polymorphism, Single Nucleotide; Prevalence; RNA, Ribosomal, 23S; Sexually Transmitted Diseases, Bacterial; Transferases | 2020 |
Infection due to Mycoplasma hominis after left hip replacement: case report and literature review.
Topics: Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Clindamycin; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycoplasma hominis; Mycoplasma Infections; Postoperative Complications | 2019 |
Postoperative Mycoplasma hominis infections after neurosurgical intervention.
Topics: Acute Disease; Adolescent; Anti-Bacterial Agents; Cervical Vertebrae; Delayed Diagnosis; Empyema, Subdural; Epidural Abscess; Fluoroquinolones; Humans; Immunosuppression Therapy; Magnetic Resonance Imaging; Male; Moxifloxacin; Mycoplasma hominis; Mycoplasma Infections; Neurosurgical Procedures; Postoperative Complications; Spinal Cord Compression; Spinal Injuries; Surgical Wound Dehiscence; Tomography, X-Ray Computed; Treatment Failure; Treatment Outcome | 2014 |
Management of Mycoplasma genitalium infections - can we hit a moving target?
Topics: Anti-Bacterial Agents; Azithromycin; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Moxifloxacin; Mycoplasma genitalium; Mycoplasma Infections; Treatment Failure | 2015 |
Meta-analysis of the efficacy of moxifloxacin in treating Mycoplasma genitalium infection.
Topics: Anti-Bacterial Agents; Fluoroquinolones; Humans; Moxifloxacin; Mycoplasma genitalium; Mycoplasma Infections; Treatment Outcome | 2017 |
Recent perspectives in the diagnosis and evidence-based treatment of Mycoplasma genitalium.
Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Drug Resistance, Bacterial; Evidence-Based Medicine; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Mycoplasma genitalium; Mycoplasma Infections; Quinolines; Urethritis; Uterine Cervicitis | 2012 |
Antimicrobial chemotherapy of Mycoplasma genitalium-positive non-gonococcal urethritis.
Topics: Anti-Infective Agents; Aza Compounds; Azithromycin; Doxycycline; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Male; Moxifloxacin; Mycoplasma genitalium; Mycoplasma Infections; Quinolines; Treatment Outcome; Urethritis | 2012 |
1 trial(s) available for moxifloxacin and Eperythrozoonosis
Article | Year |
---|---|
Time to eradication of Mycoplasma genitalium after antibiotic treatment in men and women.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; DNA, Bacterial; DNA, Ribosomal; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Longitudinal Studies; Macrolides; Male; Middle Aged; Moxifloxacin; Mycoplasma genitalium; Mycoplasma Infections; Polymerase Chain Reaction; Prospective Studies; RNA, Ribosomal, 23S; Time Factors; Treatment Outcome; Urine; Vagina; Young Adult | 2015 |
35 other study(ies) available for moxifloxacin and Eperythrozoonosis
Article | Year |
---|---|
Comparative in vitro activities of the investigational fluoroquinolone DC-159a and other antimicrobial agents against human mycoplasmas and ureaplasmas.
Topics: Aminopyridines; Anti-Bacterial Agents; Fluoroquinolones; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Mycoplasma; Mycoplasma fermentans; Mycoplasma genitalium; Mycoplasma hominis; Mycoplasma Infections; Mycoplasma pneumoniae; Ureaplasma; Ureaplasma Infections | 2008 |
Combination Therapy for Mycoplasma genitalium, and New Insights Into the Utility of parC Mutant Detection to Improve Cure.
Topics: Anti-Bacterial Agents; Azithromycin; Doxycycline; Drug Resistance, Bacterial; Humans; Macrolides; Moxifloxacin; Mycoplasma genitalium; Mycoplasma Infections | 2022 |
2021 European guideline on the management of Mycoplasma genitalium infections.
Topics: Anti-Bacterial Agents; Azithromycin; Doxycycline; Drug Resistance, Bacterial; Dysuria; Female; Humans; Macrolides; Male; Moxifloxacin; Mycoplasma genitalium; Mycoplasma Infections; Urethritis | 2022 |
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Macrolides; Moxifloxacin; Mycoplasma genitalium; Mycoplasma Infections | 2022 |
Clinical Performance of Three Commercial Molecular Diagnostic Assays for the Detection of Fluoroquinolone Resistance-Associated Mutations in Mycoplasma genitalium.
Topics: Anti-Bacterial Agents; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Macrolides; Moxifloxacin; Mutation; Mycoplasma genitalium; Mycoplasma Infections; Pathology, Molecular; RNA, Ribosomal, 23S | 2022 |
gyrA Mutations in Mycoplasma genitalium and Their Contribution to Moxifloxacin Failure: Time for the Next Generation of Resistance-Guided Therapy.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Macrolides; Male; Moxifloxacin; Mutation; Mycoplasma genitalium; Mycoplasma Infections | 2023 |
Resistance-Guided Antimicrobial Therapy Using Doxycycline-Moxifloxacin and Doxycycline-2.5 g Azithromycin for the Treatment of Mycoplasma genitalium Infection: Efficacy and Tolerability.
Topics: Anti-Bacterial Agents; Australia; Azithromycin; Doxycycline; Drug Resistance, Bacterial; Female; Homosexuality, Male; Humans; Macrolides; Male; Moxifloxacin; Mycoplasma genitalium; Mycoplasma Infections; Sexual and Gender Minorities | 2020 |
Resistance-Guided Therapy for Mycoplasma genitalium Infections.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Doxycycline; Drug Resistance, Bacterial; Humans; Moxifloxacin; Mycoplasma genitalium; Mycoplasma Infections | 2020 |
High rates of treatment failure for
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Doxycycline; England; Female; Humans; Male; Mass Screening; Middle Aged; Moxifloxacin; Mycoplasma genitalium; Mycoplasma Infections; Reproductive Health Services; Treatment Outcome; Urethritis | 2020 |
Clearance of Mycoplasma genitalium Infection With Moxifloxacin in the Presence of Quinolone Resistance-Associated Mutations.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Moxifloxacin; Mutation; Mycoplasma genitalium; Mycoplasma Infections; Quinolones; Retrospective Studies; Treatment Outcome | 2020 |
Moxifloxacin and Sitafloxacin Treatment Failure in Mycoplasma genitalium Infection: Association with parC Mutation G248T (S83I) and Concurrent gyrA Mutations.
Topics: Anti-Bacterial Agents; Bacterial Proteins; DNA Topoisomerase IV; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Mutation; Mycoplasma genitalium; Mycoplasma Infections; Treatment Failure | 2020 |
Quinolone Resistance-Associated Mutations in Mycoplasma genitalium: Not Ready for Prime Time.
Topics: Drug Resistance, Bacterial; Humans; Moxifloxacin; Mutation; Mycoplasma genitalium; Mycoplasma Infections; Quinolones | 2020 |
The Pharmacokinetics of Moxifloxacin in Cerebrospinal Fluid Following Intravenous Administration: A Report of Successfully Treated Infant with Mycoplasma hominis Meningitis.
Topics: Administration, Intravenous; Anti-Bacterial Agents; Female; Humans; Infant, Newborn; Meningitis; Moxifloxacin; Mycoplasma hominis; Mycoplasma Infections; Treatment Outcome | 2020 |
Azithromycin, minocycline, moxifloxacin and spectinomycin failure in a case with persistent
Topics: Anti-Bacterial Agents; Azithromycin; DNA Gyrase; DNA, Bacterial; Humans; Middle Aged; Minocycline; Moxifloxacin; Mycoplasma genitalium; Mycoplasma Infections; RNA, Ribosomal, 23S; Sequence Analysis, DNA; Spectinomycin; Treatment Failure; Urethritis | 2020 |
Prevalence and antibiotic resistance of
Topics: Adult; Alberta; Anti-Bacterial Agents; Cervix Uteri; Chlamydia Infections; Chlamydia trachomatis; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Fluoroquinolones; Gonorrhea; Humans; Logistic Models; Macrolides; Male; Moxifloxacin; Multivariate Analysis; Mycoplasma genitalium; Mycoplasma Infections; Neisseria gonorrhoeae; Sex Factors; Urine; Young Adult | 2017 |
Clinical Characteristics of Anorectal Mycoplasma genitalium Infection and Microbial Cure in Men Who Have Sex With Men.
Topics: Adult; Anti-Infective Agents; Azithromycin; Chlamydia trachomatis; Coinfection; Gonorrhea; Homosexuality, Male; Humans; Male; Moxifloxacin; Mycoplasma genitalium; Mycoplasma Infections; Neisseria gonorrhoeae; Pristinamycin; Proctitis; Rectal Diseases; Sexual and Gender Minorities; Sexual Behavior; Victoria; Young Adult | 2018 |
Topics: Anti-Bacterial Agents; Azithromycin; Canada; Drug Resistance, Bacterial; Female; Fluoroquinolones; Health Surveys; Humans; Male; Moxifloxacin; Mycoplasma genitalium; Mycoplasma Infections; Practice Guidelines as Topic; Prevalence; Sexually Transmitted Diseases, Bacterial | 2019 |
Prevalence of genital Mycoplasma and response to eradication treatment in patients undergoing assisted reproductive techniques.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Clindamycin; Doxycycline; Embryo Implantation; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Mycoplasma hominis; Mycoplasma Infections; Prevalence; Real-Time Polymerase Chain Reaction; Reproductive Techniques, Assisted; Semen Analysis; Sex Factors; Treatment Outcome; Ureaplasma Infections; Ureaplasma urealyticum; Young Adult | 2019 |
Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance.
Topics: Anti-Bacterial Agents; Aza Compounds; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Macrolides; Moxifloxacin; Mutation; Mycoplasma genitalium; Mycoplasma Infections; Polymerase Chain Reaction; Quinolines; RNA, Ribosomal, 23S; Sequence Analysis, DNA; Treatment Failure | 2013 |
In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strains.
Topics: Anti-Bacterial Agents; Azithromycin; DNA, Bacterial; DNA, Ribosomal; Doxycycline; Drug Resistance, Bacterial; Fluoroquinolones; Gonorrhea; Humans; Macrolides; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycoplasma genitalium; Mycoplasma Infections; Neisseria gonorrhoeae; Triazoles | 2014 |
Diagnosis and antimicrobial treatment of Mycoplasma genitalium infection: sobering thoughts.
Topics: Anti-Bacterial Agents; Azithromycin; Coinfection; Doxycycline; Drug Resistance, Bacterial; Female; Fluoroquinolones; HIV Infections; Humans; Male; Moxifloxacin; Mycoplasma genitalium; Mycoplasma Infections; Urethritis | 2014 |
Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Macrolides; Male; Middle Aged; Moxifloxacin; Mycoplasma genitalium; Mycoplasma Infections; Pristinamycin; Treatment Failure; Young Adult | 2015 |
Spontaneous Regression of Untreatable Mycoplasma genitalium Urethritis.
Topics: Anti-Bacterial Agents; Azithromycin; Doxycycline; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Mycoplasma genitalium; Mycoplasma Infections; Remission, Spontaneous; Time Factors; Treatment Failure; Urethritis | 2015 |
2015 UK National Guideline on the management of non-gonococcal urethritis.
Topics: Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Disease Management; Doxycycline; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Male; Metronidazole; Moxifloxacin; Mycoplasma genitalium; Mycoplasma Infections; Practice Guidelines as Topic; United Kingdom; Urethritis | 2016 |
Mycoplasma genitalium: a possible case of macrolide resistance from Lebanon.
Topics: Anti-Bacterial Agents; Fluoroquinolones; Humans; Moxifloxacin; Mycoplasma genitalium; Mycoplasma Infections; Treatment Outcome | 2016 |
Mycoplasma genitalium in Toronto, Ont: Estimates of prevalence and macrolide resistance.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cross-Sectional Studies; Doxycycline; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Macrolides; Male; Middle Aged; Moxifloxacin; Mycoplasma genitalium; Mycoplasma Infections; Ontario; Prospective Studies; Sex Factors; Treatment Outcome; Young Adult | 2016 |
[Mycoplasma genitalium].
Topics: Anti-Bacterial Agents; Azithromycin; Endometritis; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Mycoplasma genitalium; Mycoplasma Infections; Salpingitis; Urethritis; Uterine Cervicitis; Vaginosis, Bacterial | 2016 |
Activity of moxifloxacin against the urogenital mycoplasmas Ureaplasma spp., Mycoplasma hominis and Mycoplasma genitalium and Chlamydia trachomatis.
Topics: Anti-Infective Agents; Aza Compounds; Chlamydia Infections; Chlamydia trachomatis; Female; Female Urogenital Diseases; Fluoroquinolones; Humans; Male; Male Urogenital Diseases; Microbial Sensitivity Tests; Moxifloxacin; Mycoplasma genitalium; Mycoplasma hominis; Mycoplasma Infections; Quinolines; Ureaplasma; Ureaplasma Infections | 2008 |
Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study.
Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Mycoplasma genitalium; Mycoplasma Infections; Quinolines; Treatment Outcome | 2008 |
Pharmacokinetics of moxifloxacin in an infant with Mycoplasma hominis meningitis.
Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Child; Child, Preschool; Doxycycline; Female; Fluoroquinolones; Humans; Infant; Infant, Newborn; Male; Meningitis, Bacterial; Moxifloxacin; Mycoplasma hominis; Mycoplasma Infections; Pregnancy; Quinolines; Treatment Outcome | 2012 |
Antimicrobial efficacies of several antibiotics against uterine cervicitis caused by Mycoplasma genitalium.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Female; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mycoplasma genitalium; Mycoplasma Infections; Polymerase Chain Reaction; Quinolines; Retrospective Studies; Uterine Cervicitis | 2012 |
A novel hemotropic Mycoplasma (hemoplasma) in a patient with hemolytic anemia and pyrexia.
Topics: Anemia, Hemolytic; Anti-Bacterial Agents; Aza Compounds; Chronic Disease; Cluster Analysis; DNA, Bacterial; DNA, Ribosomal; Doxycycline; Female; Fever; Fluoroquinolones; Humans; Middle Aged; Molecular Sequence Data; Moxifloxacin; Mycoplasma; Mycoplasma Infections; Neutropenia; Phylogeny; Quinolines; RNA, Ribosomal, 16S; Sequence Analysis, DNA | 2011 |
Mycoplasma genitalium: should we treat and how?
Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Doxycycline; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Infertility, Female; Male; Moxifloxacin; Mycoplasma genitalium; Mycoplasma Infections; Pelvic Inflammatory Disease; Pregnancy; Pregnancy, Ectopic; Quinolines; Treatment Outcome; Urethritis; Uterine Cervicitis | 2011 |
Mycoplasma hominis septic arthritis with concomitant gouty arthritis.
Topics: Aged; Ankle Joint; Anti-Bacterial Agents; Arthritis, Gouty; Arthritis, Infectious; Aza Compounds; Doxycycline; Fluoroquinolones; Humans; Male; Moxifloxacin; Mycoplasma hominis; Mycoplasma Infections; Polymerase Chain Reaction; Quinolines; RNA, Ribosomal, 16S | 2012 |
Azithromycin failure in Mycoplasma genitalium urethritis.
Topics: Adult; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Mycoplasma genitalium; Mycoplasma Infections; Quinolines; Treatment Failure; Urethritis | 2006 |